Company Filing History:
4 out of 25 
2 out of 321 
1 out of 1 Years Active: 2007-2011
Title: **Innovative Contributions of Chang-Min Jung in Biotechnology**
Introduction
Chang-Min Jung, an accomplished inventor based in Seoul, South Korea, has made significant strides in the field of biotechnology with a commendable portfolio of four patents. His innovative work focuses on peptide expression methods that harness the capabilities of microorganisms, aiming to advance medical and therapeutic applications.
Latest Patents
Chang-Min Jung's recent patents showcase his groundbreaking approach to peptide antibiotic production. One of his latest inventions, titled "Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase," addresses the need for efficient expression of peptide antibiotics that exhibit antimicrobial, antifungal, and anticancer properties. This method utilizes a vector containing genes derived from specific strains that are integral to synthesizing poly-gamma-glutamate, allowing the production of these peptides directly on the microbial surface. Moreover, this invention presents an innovative solution for the mass production of peptide antibiotics without the need for purification processes, thereby enhancing its industrial applicability. Another notable patent involves the development of surface expression vectors that enable stable expression of foreign proteins on the surface of microorganisms, further demonstrating his inventive prowess in biotechnological applications.
Career Highlights
Throughout his career, Chang-Min has played vital roles in various research and development endeavors. He has been affiliated with esteemed organizations such as Bioleaders Corporation and the Korea Research Institute of Bioscience and Biotechnology. His contributions at these institutions have significantly advanced the field of biotechnology and antibiotic research.
Collaborations
Chang-Min Jung has collaborated with prominent researchers in the field, including Moon-Hee Sung and Chul-Joong Kim. These partnerships have enriched his work and facilitated the development of innovative solutions to complex biological challenges.
Conclusion
With a focus on innovative peptide expression techniques and a strong background in biotechnology, Chang-Min Jung continues to make impactful contributions to his field. His patents not only reflect his ingenuity and adaptability but also hold the potential for transformative advancements in medical therapies and microbial biotechnology.